Skip to main content
. Author manuscript; available in PMC: 2016 Oct 18.
Published in final edited form as: J Clin Endocrinol Metab. 2016 Jul 29;101(10):3827–3837. doi: 10.1210/jc.2016-1828

Table 2.

Mean and standard deviation (SD) for pQCT-derived outcomes at 60-64 years by menopausal characteristics.

Diaphysis CSA mm2 Medullary CSA mm2 Total vBMD mg/cm3 Trabecular vBMD mg/cm3 Cortical vBMD mg/cm3 Polar SSI mm3 Spine L1-L4 aBMD g/cm3 Hip aBMD g/cm3
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age at natural menopause (years)
<45 111.0 (19.6) 36.6 (13.2) 298.2 (73.2) 146.5 (36.2) 1139.9 (39.7) 204.7 (48.4) 0.85 (0.1) 0.83 (0.1)
45-49 109.7 (16.0) 37.1 (14.8) 314.5 (72.4) 167.0 (48.8) 1143.3 (44.1) 199.2 (38.4) 0.89 (0.2) 0.83 (0.1)
50-52 111.9 (14.5) 34.9 (12.1) 320.1 (64.5) 165.8 (40.3) 1149.6 (38.3) 211.8 (43.9) 0.92 (0.2) 0.86 (0.1)
53-55 112.2 (16.3) 36.2 (13.4) 331.7 (75.9) 171.5 (44.1) 1144.1 (41.8) 204.8 (43.2) 0.94 (0.2) 0.88 (0.1)
56-62 112.6 (17) 33.7 (11.1) 321.3 (54.8) 171.9 (35.4) 1149.9 (36.9) 211.9 (45.8) 0.98 (0.2) 0.89 (0.1)
p-value for trend* .2 .3 .014 .004 .3 .2 <.001 <.001
Age at hysterectomy (years)
<40 115.3 (18) 33.5 (13.1) 337.1 (66.8) 178.1 (37.1) 1150.6 (28.8) 224.7 (47.4) 0.96 (0.2) 0.9 (0.1)
40-44 113.8 (17.8) 35.6 (12.8) 343.9 (60.6) 175.9 (44.3) 1152.4 (36.9) 216.8 (47.3) 0.95 (0.2) 0.9 (0.1)
45-49 112.1 (15.6) 32.1 (12.6) 341.2 (82.2) 179.8 (44.9) 1160 (34.1) 214 (41.5) 0.99 (0.2) 0.9 (0.1)
≥50 111.9 (16.4) 34.5 (11.1) 347.8 (66.6) 179.7 (37.8) 1144.4 (43.1) 213.5 (47.2) 0.99 (0.2) 0.89 (0.1)
p-value for trend* .5 .7 .7 >.9 .6 .3 .3 >.9
Age at menarche (years)
9-10 111.2 (12.5) 31.4 (9.01) 349.3 (84) 179.9 (40.1) 1158.5 (32.5) 213.2 (34.5) 0.98 (0.1) 0.9 (0.1)
11 113 (17.1) 34 (12.7) 339.2 (69.2) 176.7 (40.6) 1145.7 (44.2) 217.2 (45.1) 0.98 (0.2) 0.9 (0.1)
12 114.4 (16) 36.5 (13.2) 340.5 (74.6) 178.5 (46.1) 1145.9 (39.8) 213.1 (45) 0.95 (0.2) 0.87 (0.1)
13 111.5 (16) 35.7 (12.3) 320.9 (69.2) 169 (41.1) 1148.3 (40) 207.9 (42.5) 0.95 (0.2) 0.86 (0.1)
14 111.5 (14.4) 34.7 (11.9) 318.9 (63.8) 168.4 (34.9) 1151.4 (33) 207.5 (39) 0.92 (0.2) 0.85 (0.1)
15-19 111.9 (17.5) 34.7 (12.8) 336.8 (68.5) 157.7 (39.8) 1150.9 (39.7) 210.9 (38.5) 0.91 (0.2) 0.84 (0.1)
p-value for trend* .4 .7 .03 .01 .9 .2 .004 <.001
Length of natural reproductive life
≤35 109.9 (18.7) 37.3 (16.1) 305.1 (70.3) 155.5 (41.9) 1140.9 (44.2) 199.3 (41.3) 0.86 (0.1) 0.8 (0.1)
36-37 109.1 (14) 34.7 (11.2) 324.2 (72.1) 168.6 (46.9) 1152.5 (40.7) 204.6 (41.4) 0.91 (0.2) 0.84 (0.1)
38-39 112 (15.4) 35.5 (11) 323.9 (65.6) 173.4 (38.1) 1151.4 (32.5) 209.7 (46.8) 0.91 (0.2) 0.85 (0.1)
40-41 112.3 (15.9) 35.9 (14.3) 339.3 (69.1) 176.3 (41.1) 1142.9 (44.7) 207.1 (39.3) 0.97 (0.2) 0.9 (0.1)
42-43 116.3 (17.6) 35.9 (11.1) 319.7 (67.8) 165.1 (38.6) 1145.4 (31.6) 220.1 (47) 0.95 (0.2) 0.87 (0.1)
≥44 109.6 (12.5) 34.5 (8.8) 316.6 (63.5) 168.8 (38.4) 1148.2 (39.3) 198 (34.6) 0.98 (0.2) 0.88 (0.1)
p-value for trend* .07 .9 .1 .02 .4 .07 <.001 <.001
Length of reproductive life (ceased surgically)
≤35 115.1 (16.4) 34.3 (12.5) 347 (70.3) 180.4 (44.9) 1154.6 (33.7) 221.4 (44.0) 0.97 (0.2) 0.90 (0.1)
36-37 115 (17.5) 38.4 (9.3) 318.4 (80.9) 179.6 (33.6) 1135.8 (35) 214.6 (53.8) 0.99 (0.2) 0.90 (0.1)
38-39 109.5 (14.2) 32.2 (11.5) 344.2 (66.3) 177.7 (45.3) 1151.8 (40.2) 213.7 (39.9) 0.95 (0.2) 0.86 (0.1)
40-41 102.6 (7.2) 24.5 (5) 405.8 (67.2) 204.6 (13.4) 1192.8 (20.9) 184.0 (7.9) 1.09 (0.01) 1.01 (0.1)
42-43 104.9 (17.8) 27.3 (8.3) 391.3 (46.6) 192.7 (21.5) 1169.6 (27.4) 198.4 (43.9) 1.1 (0.2) 0.90 (0.1)
≥44 122.7 (12.2) 42.9 (16.3) 317.1 (89.3) 159.1 (57.8) 1108.9 (77.5) 235.2 (49.7) 0.92 (0.2) 0.88 (0.1)
p-value for trend .01 .2 .7 .7 .9 .02 >.9 .7
Length of HRT use (years)
≥13 118.6 (17) 35.4 (13.9) 348.4 (66.4) 174.5 (37.8) 1165.2 (38.7) 236.6 (49.1) 1.01 (0.2) 0.90 (0.1)
11-12 111.9 (12.3) 32.7 (8.17) 337.6 (66.8) 179.2 (35.7) 1161.5 (32.1) 215.1 (33.5) 0.94 (0.1) 0.88 (0.1)
9-10 111.3 (14.2) 32 (8.95) 335.5 (67.2) 175.1 (37.6) 1156.8 (35.2) 213.9 (43.5) 0.95 (0.2) 0.86 (0.1)
7-8 113.8 (13.7) 33.6 (11) 334.1 (70.8) 178.5 (40.3) 1152.8 (34.7) 216.6 (35) 0.95 (0.1) 0.87 (0.1)
5-6 112.3 (16.4) 35.7 (13.4) 316.7 (64.6) 168.1 (38.9) 1141.1 (38) 211.9 (46.3) 0.97 (0.2) 0.87 (0.1)
3-4 113.3 (16.1) 34.8 (12.4) 340.1 (73.4) 175.6 (43.8) 1146.9 (38) 213.5 (41) 0.96 (0.2) 0.88 (0.1)
1-2 114.1 (17.4) 36.4 (14.3) 334.6 (81.9) 177.9 (51.4) 1144 (45.7) 212.6 (48.7) 0.94 (0.2) 0.88 (0.1)
< 1 111.4 (13.1) 35.1 (9.44) 326.4 (66.2) 170.3 (39.7) 1145 (39) 204.4 (39.9) 0.95 (0.2) 0.86 (0.1)
Never used HRT 111.7 (16.4) 36.3 (13.2) 323.7 (66.7) 167.5 (40.2) 1146.7 (38.6) 207 (43.4) 0.92 (0.2) 0.86 (0.1)
p-value for trend* .1 .03 .07 .07 .001 <.001 .002 .1
Last HRT use
In the last year 115 (15.2) 33.1 (12) 354.1 (65.5) 175.7 (35) 1165.8 (33.8) 226.1 (45.6) 1.01 (0.1) 0.9 (0.1)
1-5 years ago 114.1 (14.6) 33.9 (10.9) 343.8 (69.8) 174.4 (41.7) 1152.2 (34.6) 217.2 (46.4) 0.94 (0.2) 0.85 (0.1)
> 5 years ago 112.6 (15.5) 35 (12.1) 326.9 (70.9) 174.8 (42.9) 1146.5 (39.8) 211.5 (41.5) 0.95 (0.2) 0.87 (0.1)
Never used HRT 111.7 (16.4) 36.3 (13.2) 323.7 (66.7) 167.5 (40.2) 1146.7 (38.6) 207 (43.4) 0.92 (0.2) 0.86 (0.1)
p-value (category)* .4 .2 .01 .2 .007 .02 .001 .1
*

Tests for trend or categories were based on regression models where bone outcomes were logged, and age at period cessation, and length of reproductive life and length of HT use were included as months since birth.